Qube Research & Technologies (QRT)’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3M Buy
663,319
+350,507
+112% +$4.7M 0.01% 1381
2026
Q1
$4.66M Buy
+312,812
New +$6.96M 0.01% 1698
2022
Q4
Sell
-21,145
Closed -$58K 2847
2022
Q3
$58K Sell
21,145
-4,170
-16% -$17.7K ﹤0.01% 2106
2022
Q2
$103K Buy
+25,315
New +$80.3K ﹤0.01% 1944
2021
Q1
Sell
-8,882
Closed -$427K 2271
2020
Q4
$427K Buy
+8,882
New +$416K 0.01% 1195

Other funds holding OLMA

Qube Research & Technologies (QRT)'s OLMA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Olema Pharmaceuticals (OLMA) stake by 112% in Q2 2026, buying an estimated $4.7M and bringing the position to 663,319 shares worth $8.3M. The position accounts for 0.01% of the portfolio, ranked #1381.

Qube Research & Technologies (QRT) first reported a position in OLMA in Q4 2020 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 663,319 shares of Olema Pharmaceuticals worth $8.3M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 350,507 Olema Pharmaceuticals shares in Q2 2026, an estimated $4.7M.
  • Olema Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1381 holding.
  • Qube Research & Technologies (QRT) first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.